Showing 1 - 7 results of 7 for search 'Büşra Kaplan', query time: 3.07s Refine Results
  1. 1
    A new perspective on the clinical features of vestibular migraine

    A new perspective on the clinical features of vestibular migraine by Gülin Gökçen Kesici, Büşra Kaplan

    Published 2024-12-01
    Get full text
    Article
  2. 2
    SARS-CoV-2 spike protein S1 subunit induces potent neutralizing responses in mice and is effective against Delta and Omicron variants

    SARS-CoV-2 spike protein S1 subunit induces potent neutralizing responses in mice and is effective against Delta and Omicron variants by Tarlan Mamedov, Tarlan Mamedov, Damla Yuksel, Irem Gurbuzaslan, Burcu Gulec, Gulshan Mammadova, Aykut Ozdarendeli, Aykut Ozdarendeli, Shaikh Terkis Islam Pavel, Shaikh Terkis Islam Pavel, Hazel Yetiskin, Hazel Yetiskin, Busra Kaplan, Busra Kaplan, Muhammet Ali Uygut, Gulnara Hasanova

    Published 2023-11-01
    Get full text
    Article
  3. 3
    Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variants

    Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variants by Tarlan Mamedov, Tarlan Mamedov, Damla Yuksel, Irem Gurbuzaslan, Merve Ilgin, Burcu Gulec, Gulshan Mammadova, Aykut Ozdarendeli, Aykut Ozdarendeli, Shaikh Terkis Islam Pavel, Shaikh Terkis Islam Pavel, Hazel Yetiskin, Hazel Yetiskin, Busra Kaplan, Busra Kaplan, Muhammet Ali Uygut, Gulnara Hasanova

    Published 2023-08-01
    Get full text
    Article
  4. 4
    Development of an Inactivated Vaccine against SARS CoV-2

    Development of an Inactivated Vaccine against SARS CoV-2 by Shaikh Terkis Islam Pavel, Hazel Yetiskin, Muhammet Ali Uygut, Ahmet Furkan Aslan, Günsu Aydın, Öznur İnan, Büşra Kaplan, Aykut Ozdarendeli

    Published 2021-11-01
    Get full text
    Article
  5. 5
    Efficacy of Inactivated Bivalent SARS-CoV-2 Vaccines Targeting Ancestral Strain (ERAGEM), Delta, and Omicron Variants

    Efficacy of Inactivated Bivalent SARS-CoV-2 Vaccines Targeting Ancestral Strain (ERAGEM), Delta, and Omicron Variants by Busra Kaplan, Shaikh Terkis Islam Pavel, Muhammet Ali Uygut, Merve Tunc, Yesari Eroksuz, Ilhami Celik, Esma Eryilmaz Eren, Gulay Korukluoglu, Ates Kara, Aykut Ozdarendeli, Hazel Yetiskin

    Published 2025-02-01
    Get full text
    Article
  6. 6
    Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in <i>Nicotiana benthamiana</i> Plant as a Vaccine Candidate against COVID-19

    Production and Characterization of Nucleocapsid and RBD Cocktail Antigens of SARS-CoV-2 in <i>Nicotiana benthamiana</i> Plant as a Vaccine Candidate against COVID-19 by Tarlan Mamedov, Damla Yuksel, Merve Ilgın, Irem Gürbüzaslan, Burcu Gulec, Gulshan Mammadova, Aykut Ozdarendeli, Hazel Yetiskin, Busra Kaplan, Shaikh Terkis Islam Pavel, Muhammet Ali Uygut, Gulnara Hasanova

    Published 2021-11-01
    Get full text
    Article
  7. 7
    Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up

    Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up by Zafer Sezer, Shaikh Terkis Islam Pavel, Ahmet Inal, Hazel Yetiskin, Busra Kaplan, Muhammet Ali Uygut, Ahmet Furkan Aslan, Adnan Bayram, Mumtaz Mazicioglu, Gamze Kalin Unuvar, Zeynep Ture Yuce, Gunsu Aydin, Refika Kamuran Kaya, Ihsan Ates, Ates Kara, Aykut Ozdarendeli

    Published 2024-01-01
    Get full text
    Article

Search Tools: